Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Clinical Endocrinology
|
September 25, 2007
Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia
L W Cho, E S Kilpatrick, V Jayagopal, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 9, 2012
High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in Type 2 diabetes: a pilot randomized controlled trial
D D Mellor, L A Madden, K A Smith, et al.
Clinical Endocrinology
|
June 13, 2008
Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome
L W Cho, E S Kilpatrick, B G Keevil, et al.
Scientific Reports
|
November 15, 2017
Effect of soy on bone turn-over markers in men with type 2 diabetes and hypogonadism - a randomised controlled study
T Sathyapalan, M Aye, A S Rigby, et al.
Clinical Endocrinology
|
November 22, 2013
Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
H Kahal, G Abouda, A S Rigby, et al.
Diabetes & Vascular Disease Research
|
July 10, 2012
Diagnostic performance of using one- or two-HbA1c cut-point strategies to detect undiagnosed type 2 diabetes and impaired glucose regulation within a multi-ethnic population
S A Mostafa, K Khunti, E S Kilpatrick, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
May 10, 2018
Soy isoflavones improve cardiovascular disease risk markers in women during the early menopause
T Sathyapalan, M Aye, A S Rigby, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 14, 2013
Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment
J Konya, J M Ng, H Cox, et al.
Diabetologia
|
August 13, 2009
Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT
S E Siegelaar, E S Kilpatrick, A S Rigby, et al.
Annals of Clinical Biochemistry
|
May 18, 2006
Investigation into possible causes of interference in serum testosterone measurement in women
A H Heald, A Butterworth, J W Kane, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Clinical Endocrinology
|
September 25, 2007
Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia
L W Cho, E S Kilpatrick, V Jayagopal, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 9, 2012
High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in Type 2 diabetes: a pilot randomized controlled trial
D D Mellor, L A Madden, K A Smith, et al.
Clinical Endocrinology
|
June 13, 2008
Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome
L W Cho, E S Kilpatrick, B G Keevil, et al.
Scientific Reports
|
November 15, 2017
Effect of soy on bone turn-over markers in men with type 2 diabetes and hypogonadism - a randomised controlled study
T Sathyapalan, M Aye, A S Rigby, et al.
Clinical Endocrinology
|
November 22, 2013
Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
H Kahal, G Abouda, A S Rigby, et al.
Diabetes & Vascular Disease Research
|
July 10, 2012
Diagnostic performance of using one- or two-HbA1c cut-point strategies to detect undiagnosed type 2 diabetes and impaired glucose regulation within a multi-ethnic population
S A Mostafa, K Khunti, E S Kilpatrick, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
May 10, 2018
Soy isoflavones improve cardiovascular disease risk markers in women during the early menopause
T Sathyapalan, M Aye, A S Rigby, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 14, 2013
Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment
J Konya, J M Ng, H Cox, et al.
Diabetologia
|
August 13, 2009
Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT
S E Siegelaar, E S Kilpatrick, A S Rigby, et al.
Annals of Clinical Biochemistry
|
May 18, 2006
Investigation into possible causes of interference in serum testosterone measurement in women
A H Heald, A Butterworth, J W Kane, et al.
Page
of 8